Tranexamic Acid in Hip Fracture Surgery
NCT02736383 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 142
Last updated 2023-09-22
Summary
To determine if TXA utilization is effective at reducing transfusion rates in elderly patients undergoing surgery for treatment of a hip fractures.
Conditions
- Hip Fracture
Sponsors & Collaborators
-
Spectrum Health Hospitals
lead OTHER
Principal Investigators
-
Blake W Miller, DO · Spectrum Health Hospitals
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-05-31
- Primary Completion
- 2017-07-31
- Completion
- 2017-07-31
More Related Trials
-
Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion
NCT03063892 ·Status: RECRUITING ·Phase: PHASE4
-
Blood Loss After Early TXA in Hip Fractures.
NCT04488367 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Tranexamic Acid Use in Acute Hip Fractures
NCT02947529 ·Status: COMPLETED ·Phase: PHASE4
-
Does Tranexamic Acid Reduce the Need for Blood Transfusions in Patients Undergoing Hip Fracture Surgery?
NCT01714336 ·Status: COMPLETED ·Phase: PHASE4
-
Topical Tranexamic Acid (TXA) in Hip Fractures
NCT02993341 ·Status: COMPLETED ·Phase: PHASE3
-
Single Dose of Tranexamic Acid and Blood Loss, in Elderly Patients With Hip Fracture
NCT03251469 ·Status: UNKNOWN ·Phase: PHASE2
-
Tranexamic Acid Use and Blood Loss in Total Hip Arthroplasty
NCT02989155 ·Status: COMPLETED
-
Early Administration Of Tranexamic Acid And Acute Blood Loss In Patients With Hip Fractures
NCT05518279 ·Status: WITHDRAWN ·Phase: PHASE3
-
Role of Topical Tranexamic Acid in Total Hip Arthroplasty
NCT01866943 ·Status: TERMINATED ·Phase: PHASE2
-
The Effect of Tranexamic Acid on Blood Loss and Transfusion Requirements Following Open Femur Fracture Surgery
NCT03679481 ·Status: WITHDRAWN ·Phase: PHASE4
-
Tranexamic Acid (TXA) in Hip Arthroscopy
NCT05710146 ·Status: WITHDRAWN ·Phase: PHASE3
-
The Effect of Tranexamic Acid on Transfusion Rates in Intertrochanteric Hip Fractures
NCT01940536 ·Status: WITHDRAWN ·Phase: PHASE4
-
Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty
NCT01683955 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Study: TXA, Anticoagulant, Orthopaedic Trauma
NCT07116395 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Effect of Intravenous Tranexamic Acid on Reduction of Blood Losses in Hip Fracture Patients
NCT03211286 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Preoperative Autologous Blood Donation and Tranexamic Acid in Revision Total Hip Arthroplasty
NCT02747615 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Topical and Intravenous Tranexamic Acid in Total Hip Arthroplasty
NCT02312440 ·Status: COMPLETED ·Phase: PHASE3
-
Tranexamic Acid Use on Pain, Mobility and Bleeding Following Total Hip and Total Knee Arthroplasty
NCT06208267 ·Status: RECRUITING ·Phase: NA
-
Clinical Trial to Assess the Efficacy of Tranexamic Acid in Reducing Blood Loss in Hip Fracture Patients.
NCT05489185 ·Status: UNKNOWN ·Phase: PHASE4
-
Tranexamic Acid in HIp Fracture Surgery (THIF Study)
NCT00327106 ·Status: COMPLETED ·Phase: PHASE3
-
Tranexamic Acid Dosing for Total Joint Arthroplasty
NCT02584725 ·Status: COMPLETED ·Phase: PHASE4
-
Study Comparing Topical Versus Intravenous Tranexamic Acid in Anterior Total Hip Arthroplasty
NCT03359525 ·Status: UNKNOWN ·Phase: PHASE4
-
Tranexamic Acid in Hip Fracture Patients
NCT01326403 ·Status: UNKNOWN ·Phase: NA
-
Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced?
NCT01535781 ·Status: TERMINATED ·Phase: NA
-
A Dose-response Study of Tranexamic Acid in Total Hip Arthroplasty
NCT03822793 ·Status: COMPLETED ·Phase: PHASE2